MGX Insider Trading Activity and SEC Form 4 Filings
MGX insider trading summary
Over the past 12 months, insiders at Metagenomi Therapeutics, Inc. (MGX) reported 10 sales worth $28K by 4 insiders and 2 open-market purchases worth $23K by 1 insider on SEC Form 4. Net insider selling was $5K.
Latest MGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Laurence Reid | Insider | Buy | $23K (19,883 @ $1.17) |
| Sep 9, 2026 | Laurence Reid | Insider | Buy | $138 (117 @ $1.18) |
| Jun 5, 2026 | Matthew Wein | See Remarks | Sell | $725 (558 @ $1.30) |
| Jun 5, 2026 | Pamela Wapnick | Chief Financial Officer | Sell | $4K (2,884 @ $1.30) |
| Jun 5, 2026 | Jian Irish | See Remarks | Sell | $5K (3,737 @ $1.30) |
| Mar 5, 2026 | Jian Irish | Chief Executive Officer | Sell | $3K (1,607 @ $1.60) |
| Mar 5, 2026 | Pamela Wapnick | Chief Financial Officer | Sell | $3K (1,581 @ $1.60) |
| Mar 5, 2026 | Matthew Wein | See Remarks | Sell | $771 (482 @ $1.60) |
| Dec 5, 2025 | Matthew Wein | See Remarks | Sell | $353 (199 @ $1.77) |
| Dec 5, 2025 | Brian C. Thomas | Insider | Sell | $7K (3,830 @ $1.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.